Search Results 1291-1300 of 18411 for Immunode

1. Extension Study of Mavacamten (MYK-461) in Adults With Symptomatic Obstructive Hypertrophic Cardiomyopathy Previously Enrolled in PIONEER - Mayo Clinic

   Has a positive serologic test at Screening for infection with human immunodeficiency virus, hepatitis C virus, or hepatitis B virus. Since enrollment into ...

2. A Study to Assess the Safety and Preliminary Effectiveness of Tafasitamab or Tafasitamab Plus Lenalidomide in Addition to R-CHOP in Patients with Newly Diagnosed Diffuse Large B-Cell Lymphoma (DLBCL) - Mayo Clinic

   known seropositive for or history of active viral infection with human immunodeficiency virus (HIV);; known active bacterial, viral, fungal, mycobacterial ...

3. Cytarabine With or Without SCH 900776 in Treating Adult Patients With Relapsed Acute Myeloid Leukemia - Mayo Clinic

   Human immunodeficiency virus (HIV)-positive patients receiving anti-retroviral therapy or who have a prior history of acquired immunodeficiency syndrome ...

4. ACTIV-5 / Big Effect Trial (BET-B) for the Treatment of COVID-19 - Mayo Clinic

   Has a malignancy currently receiving immunosuppressive chemotherapy, immunodeficiency, uncontrolled opportunistic infection, or uncontrolled cirrhosis. Has ...

5. Testing Teclistamab (TECVAYLI) In Combination With Iberdomide For Hard-to-Treat Multiple Myeloma - Mayo Clinic

   * Human immunodeficiency virus (HIV)-infected patients on effective anti-retroviral therapy with undetectable viral load within 6 months are eligible for ...

6. Safety, Pharmacokinetics and Efficacy of Dupilumab in Patients ≥6 Months to <6 Years With Severe Atopic Dermatitis (Liberty AD PRESCHOOL) - Mayo Clinic

   Known history of human immunodeficiency virus (HIV) infection or HIV seropositivity at the screening visit; History of malignancy at any time before the ...

7. Ibrutinib in Treating Minimal Residual Disease in Patients With Chronic Lymphocytic Leukemia After Front-Line Therapy - Mayo Clinic

   ... immunodeficiency virus (HIV) infection and bleeding disorders. Participating Mayo Clinic locations. Study statuses change often. Please contact the study ...

8. A Phase I, Multi-Center, Open Label, Dose De-escalation and Expansion Study of Gemcitabine and Cisplatin with AG120 or Pemigatinib for Advanced Cholangiocarcinoma - Mayo Clinic

   ... immunodeficiency virus (HIV) antibody results, or acquired immunodeficiency syndrome (AIDS) related illness. Note: Subjects with a sustained viral response ...

9. Drug allergy - Doctors and departments - Mayo Clinic

   Rank, M.D.. Internist; Pediatrician; Allergist-Immunologist. Phoenix, AZ. Areas of focus: Immunotherapy, Eosinophilic esophagitis, Primary immunodeficiency, ...

10. A Study to Evaluate Trabectedin with Olaparib in Advanced Unresectable or Metastatic Sarcoma - Mayo Clinic

    Immunocompromised patients; e.g., patients who are known to be serologically positive for human immunodeficiency virus (HIV). Patients with known active ...